Luoxin Pharmaceuticals Group Stock Co., Ltd. engages in the research and development, manufacture, and trading of drugs in China. The company provides antiviral, anti-infective, respiratory and digestive system, nervous and endocrine system, cardiovascular system, oncology, and anti-allergic APIs and intermediates, as well as antipyretic, analgesics, and anti-inflammatory APIs and intermediates. It also offers medical treatment and health care services. The company was formerly known as Zhejiang Doyin Pump Industry Co., Ltd. and changed its name to Luoxin Pharmaceuticals Group Stock Co., Ltd. in April 2020. Luoxin Pharmaceuticals Group Stock Co., Ltd. was founded in 1998 and is based in Linyi, China.
Metrics to compare | 002793 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship002793PeersSector | |
---|---|---|---|---|
P/E Ratio | −6.7x | −13.2x | −0.5x | |
PEG Ratio | 0.08 | 0.04 | 0.00 | |
Price/Book | 4.4x | 3.9x | 2.6x | |
Price / LTM Sales | 2.5x | 6.8x | 3.3x | |
Upside (Analyst Target) | - | −9.8% | 43.5% | |
Fair Value Upside | Unlock | −14.8% | 6.8% | Unlock |